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Review Article
Diagnostic Hematology
Purpose and Criteria for Blood Smear Scan, Blood 
Smear Examination, and Blood Smear Review
Gene Gulati, Ph.D., Jinming Song, M.D., Alina Dulau Florea, M.D., and Jerald Gong, M.D.
Department of Pathology, Anatomy, and Cell Biology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, USA
A microscopic examination of an appropriately prepared and well-stained blood smear by 
a knowledgeable laboratory professional is necessary and clinically useful in a number of 
circumstances and for a variety of reasons. In this article, an attempt is made to delineate 
the purpose and criteria for blood smear examination in a variety of circumstances that 
are encountered in everyday laboratory hematology practice. A blood smear scan serves 
to at least (a) verify the flagged automated hematology results and (b) determine if a man-
ual differential leukocyte count needs to be performed. Blood smear examination/manual 
differential leukocyte count with complete blood count (CBC) provides the complete he-
matologic picture of the case, at least from the morphologic standpoint. Blood smear re-
view with or without interpretation serves to ensure that no clinically significant finding is 
missed, besides providing diagnosis or diagnostic clue(s), particularly if and when inter-
preted by a physician.
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INTRODUCTION
The most commonly performed test in a clinical hematology lab-
oratory is a complete blood count, generally referred to as CBC, 
or infrequently as Hemogram. The second most commonly per-
formed hematologic test is what is traditionally called differential 
leukocyte count or DIFF. Currently available automated hematol-
ogy analyzers are capable of performing both of these tests fairly 
reliably, efficiently, and cost-effectively [1-5]. A microscopic ex-
amination of an appropriately prepared and well-stained blood 
smear by a knowledgeable laboratory professional is, however, 
necessary and clinically useful in a number of circumstances 
and for a variety of reasons [6-10]. The microscopic examination 
may be limited to a blood smear scan or may include a com-
plete blood smear examination with manual differential leuko-
cyte count and/or a blood smear review. In this article, we have 
attempted to define and delineate the purpose and criteria for 
each of these 3 types of smear examination, as practiced by 
professionals in hematology laboratories around the world. 
THREE TYPES OF SMEAR EXAMINATION
1. Blood Smear Scan (BSS)
Synonyms: platelet scan, platelet estimate, blood smear 
examination without a DIFF.
A BSS is usually performed to verify the automated platelet 
count, particularly if it is flagged by the analyzer for verification 
or if it is significantly lower than the lowest limit of the reference 
range. Many laboratories opt to verify the automated platelet 
count when it is below 100×109/L on a new patient or when a 
delta-check fails with a significant drop in the platelet count (≥
50% drop) on follow-up blood counts. Verification of platelet 
count below 100×109/L is important because pseudo-thrombo-
cytopenia of this magnitude may unnecessarily trigger a hema-
tology consult, additional laboratory work-up, postponement of 
surgery/special procedure, and/or a platelet transfusion. Addi-
tional reasons to perform a blood smear scan include (a) verifi-
cation of the remaining CBC results that are flagged by the ana-
lyzer, (b) to determine if the automated DIFF result that is 
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flagged by the analyzer is reliable and thereby reportable or a 
manual DIFF needs to be performed and reported instead of 
the automated DIFF, and (c) to determine the suitability of the 
smear and its staining quality for the manual DIFF and to select 
the area for performing the manual DIFF, if needed. It is usually 
performed by a technical person in the laboratory. 
 For verification of the platelet count, the entire blood smear, 
including the feather edge, lateral edges, readable area and 
thick area, should be examined first under 10× dry objective 
(i.e. magnification of ×100) looking for clumps of platelets. 
Large clumps are easily discernible under this magnification but 
small clumps may not be clearly visible, thereby prompting ex-
amination under higher magnification, which may be 40× dry 
objective (i.e. ×400 magnification), 50× oil immersion objective 
(i.e. ×500 magnification) or 100× oil immersion objective (i.e. 
×1,000 magnification). While examining under higher magnifi-
cation, it is important to note if red cell fragments, organisms 
(bacteria and fungi), and/or giant platelets are present in signifi-
cant number (more than occasional). The presence of signifi-
cant number of red cell fragments is frequently associated with 
falsely high platelet count whereas the presence of significant 
number of giant platelets is often associated with falsely low 
platelet count [11, 12]. The presence of bacteria and/or fungi 
has been associated with falsely high platelet counts [13-16]. If 
clumps are present, the automated platelet count is often unre-
liable and consequently not reportable. In such cases, a platelet 
scan should be reported in qualitative terms as normal with 
clumps, increased with clumps or decreased with clumps. 
 To obtain a reliable platelet count on specimens revealing 
platelet clumps on blood smear, it is necessary either to (a) vor-
tex the specimen for 1 to 2 min at the highest speed and rerun 
through the analyzer or (b) collect the specimen in a citrated 
tube (blue-top vacutainer tube) instead of EDTA-anticoagulated 
tube (lavender-top tube) and run through the analyzer. The for-
mer procedure is successful in disaggregating the platelet clumps 
and consequently generating a reliable platelet count, as judged 
by platelet estimate from the smear made from the vortexed 
specimen, in approximately 50% of cases [17]. In the other 50% 
of cases the disaggregation of platelet clumps is either incom-
plete or does not occur. The use of citrated blood specimen to 
count platelets is successful in over 90% of cases but under-
standably requires subjecting the patient to another venipunc-
ture and multiplication of the platelet count by 1.1 for the citrated 
blood dilution factor, prior to reporting. In the absence of clump-
ing or in cases with rare small platelet clumps, an estimated 
platelet count may be obtained by determining either (a) the av-
erage number of platelets per field under 100× oil immersion 
objective (i.e. ×1,000 magnification) and multiplying it by 15 
(range of multiplication factors used by various laboratories var-
ies between 10 and 20 for manually made wedge smears) or (b) 
the highest number of platelets in a field in the readable area 
of the smear under 100× oil immersion objective (i.e. ×1,000 
magnification) and multiplying it by 10. The latter has worked 
fine for me personally with smears made and stained by auto-
mated smear makers/stainers (SP 100 and SP-1000) from Sys-
mex Inc. (Mundelein, IL, USA). 
 Based on our experience and a review of the literature on 
performance evaluation of currently available analyzers, we sug-
gest that the criteria for a blood smear scan should include (a) 
CBC and/or DIFF results flagged by the automated analyzers for 
verification, (b) initial platelet count below 100×109/L, whether 
flagged or not flagged by the analyzer, (c) follow-up platelet 
counts of over 30×109/L with delta failure flag indicating ≥50% 
drop in the count, and (d) when the analyzer generates any one 
or more of these flags: platelet clumps, giant/large platelets, red 
cell fragments, and qualitative white cells-associated flags (also 
called morphologic, suspect, or interpretive flags), such as blasts, 
atyps, immature granulocytes, and left shift. The reason for the 
inclusion of criteria (c) is the clinical suspicion of heparin-in-
duced thrombocytopenia in a majority of such cases. A delta 
failure flag associated with an increase in platelet count is not 
included in the criteria, however, because (i) its commonest 
cause is platelet transfusion with the expected rise in count, and 
(ii) it is a frequently encountered finding in daily laboratory he-
matology practice, at least in large medical centers. 
 If the smear scan reveals the presence of immature/abnor-
mal/atypical white cells, a manual DIFF is generally reflex-or-
dered, performed, and resulted in place of the automated DIFF. 
Whether or not every smear with even one immature/abnormal/
atypical cell needs a manual DIFF, irrespective of being the ini-
tial one or a follow-up one, is debatable. In our opinion, initial 
smears with a rare but clearly identifiable cell, such as a blast, a 
hairy cell, or a myeloma cell, or a suspect but not clearly identi-
fiable cell, needs a manual DIFF. In the presence of other types 
of immature/abnormal/atypical cells, however, laboratories may 
choose to perform manual DIFF only if their number exceeds a 
predetermined threshold. While performing a blood smear scan, 
a notation should also be made of all significant morphologic 
abnormalities, if present, particularly if it is the initial smear ex-
amination of a patient at each admission or an infrequent out-
patient visit.
Gulati G, et al.
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2. Blood Smear Examination (BSE)
Synonyms: manual DIFF, DIFF. 
BSE, traditionally referred to as DIFF or manual DIFF, is gener-
ally performed by a member of the technical staff of the clinical 
hematology laboratory. It typically includes a 100-cell DIFF and 
evaluation of morphology of blood cells (red cells, white cells 
and platelets), in addition to verification of the flagged auto-
mated CBC results and a platelet estimate. Clinical laboratories 
with the state-of-the-art hematology analyzers usually perform 
the blood smear examination only when (a) automated DIFF re-
sult is considered unreliable and thereby un-reportable, based 
on either the flags generated by the analyzer, morphologic, sus-
pect or interpretive flags in particular, and/or by performing a 
blood smear scan, (b) a clinician specifically so requests, and/or 
(c) certain criteria developed by the clinical laboratory are met. 
The laboratory-developed criteria are generally based on the pa-
tient population served and the clinical significance of the ab-
normal CBC and/or automated DIFF results. Additional factors, 
such as the reliability of the automated flagging system and 
overall workload and the staffing-level of the laboratory, may also 
influence the criteria development process. Guidelines proposed 
by the International Consensus Group for Hematology Review 
are available at www.ISLH.org [10] for individual laboratories to 
consider while developing their own set of criteria. The labora-
tory-developed criteria may include numerical results and/or 
qualitative flags generated by the automated analyzers. Numeri-
cal results may include both the CBC and the DIFF results, 
whether flagged or not by the analyzer for verification. The list of 
criteria used in the Clinical Hematology Laboratory at Thomas 
Jefferson University Hospital in Philadelphia, Pennsylvania, USA 
is provided here as an example of a set of laboratory-developed 
criteria (Table 1). Any and all of these criteria may be modified 
to meet the needs of the patient population served at a given in-
stitution. At our institution, we have also modified this set of cri-
teria a few times over the years based upon the changes in the 
patient population, the workload and the automated hematology 
system used for the CBC and the DIFF. 
 From the clinical standpoint, blood smear examination serves 
3 important objectives. First, it serves as a quality control tool in 
verifying the results generated by the automated analyzers. Sec-
ond, it allows for identification of abnormal/immature/atypical 
cells, if present. Third, it allows for recognition of clinically signifi-
cant morphologic abnormalities, which the analyzers are incapa-
ble of either flagging or detecting and identifying. Currently avail-
able automated hematology analyzers do not generate any re-
portable information about the presence of many of the red cell 
abnormalities (elliptocytes/ovalocytes, target cells, sickle cells, 
acanthocytes, echinocytes, SC crystalloids, stomatocytes, tear 
Table 1. Criteria for blood smear scan and/or blood smear examination at Thomas Jefferson University Hospital    
Adults Infants
A. Based on CBC  
WBC (×109/L) Initial*  <2.0 or >30.0 
    Or Delta failure of - 300% for WBC of 0.1 to 1.0
                                + 300% for WBC of >10
Hb (g/dL) Initial <8 (for ≥  8 days old) <14 (for 0-7 days old)
  (mmol/L) <5.0 <8.7
RBC (×1012/L) Initial >6.0 (for females over 7 days old) >6.5 (for males over 7 days old) 
  MCV (fL) Initial <60 or >110 (for >7 days old) <85 or >125 (for 0-7 days old)
PLT (×109/L) Initial <100 or >999 or >30 with delta failure of -50% or greater
  NRBC (per 100 WBC) Initial >2 (for over 7 days old) >  50 (for 0-7 days old)
B. Based on automated DIFF results
Lymphocytes (×109/L) Initial >7.0 (for >14 yr old) >10.0 (for1-14 yr old) >14.0 (for <1 yr old)
Monocytes (×109/L) Initial >3.0
Eosinophils (×109/L) Initial >2.0
Basophils (×109/L) Initial >0.5
Qualitative Flags WBC abnormal scattergram, Immature granulocytes, Left shift, Atypical lymphocytes, Blasts, NRBC
*Initial: first smear on a new patient per admission or an infrequent outpatient visit.
Abbreviations: CBC, complete blood count; WBC, white blood cell; RBC, red blood cell; MCV, mean corpuscular volume; PLT, platelet; NRBC, nucleated red 
blood cell; DIFF, differential leukocyte count.
Gulati G, et al.
Blood smear examination
4 www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.1.1
drop cells, rouleaux, Howell Jolly bodies, Pappenheimer bodies, 
basophilic stippling, intraerythrocytic organisms, etc), white cell 
abnormalities (Auer rods, toxic granulation, toxic vacuolization, 
Dohle bodies, hypogranular/agranular granulocytes intraleuko-
cytic organisms, etc), and platelet abnormalities (platelet satellit-
osis, abnormal granulation, and hypogranulation/agranulation 
bizarre platelets). The analyzers are fairly reliable, but not 100% 
sensitive and 100% specific, in generating (a) platelet clump flag 
in the presence of platelet clumping and (b) red cell agglutina-
tion flag in the presence of red cell agglutination. However, none 
of the analyzers currently generate any flag to indicate the pres-
ence of white cell clumps. In the face of these limitations of the 
automated analyzers, it would be ideal but perhaps neither prac-
tical nor cost-effective to include a blood smear scan or blood 
smear examination on either (a) every new patient, irrespective 
of CBC and DIFF results being normal or abnormal or (b) at least 
on those with any level of abnormality in any one or more pa-
rameters of CBC and/or DIFF.
 A complete blood smear examination, like the blood smear 
scan, begins with a visual inspection for acceptable quality of 
the smear and the stain and for absence of macroscopic 
scratches and stain precipitate(s). An acceptable smear is then 
examined under 10× dry objective (×100 magnification), first to 
recheck the stain quality and then to look for (a) clumps of 
platelets, white cells and red cells, (b) extracellular organisms 
(microfilaria), (c) cryoprecipitate(s), (d) rouleaux formation, and 
(e) fibrin strands. All areas of the smear (feather edge, lateral 
edges, thin readable area next to the feather edge, and the thick 
area away from the feather edge) are examined at this magnifi-
cation. The findings at ×100 magnification are confirmed by ex-
amining the smear at higher magnification, either under 40× 
dry objective (×400 magnification), 50x oil objective (×500 
magnification), and/or under 100× oil objective (×1,000 magni-
fication). All of these findings have clinical relevance. The clini-
cal relevance of platelet clumping has been described above 
under the blood smear scan. 
 The presence of white cell clumps, an infrequently encoun-
tered finding, is generally associated with infectious conditions 
(clumping of neutrophils in particular) and/or lymphoprolifera-
tive disorders (clumping of lymphocytes in particular). It may 
cause a false decrease in the white blood cell (WBC) count and 
may cause difficulty in obtaining reliable DIFF results. To obtain 
reliable WBC result in such cases, one may attempt to either in-
cubate the EDTA-anticoagulated blood specimen at 37°C for 10-
15 min or vortex it at the highest speed for 1-2 min, prior to re-
running through the analyzer. Alternatively, the blood specimen 
may be collected in citrated tube (blue-top tube), run through 
the analyzer, and the WBC result multiplied by 1.1 for the ci-
trated blood dilution factor, prior to reporting. If all interventions 
fail, one may report the WBC result with a comment that the re-
sult may be unreliable due to clumps. 
 Red cell agglutination indicates the presence of cold-reacting 
red cell agglutinin(s) and it causes a false increase in mean cor-
puscular hemoglobin (MCH) and mean corpuscular hemoglo-
bin concentration (MCHC) and a false decrease in the red blood 
cell (RBC) count and Hct. It may also cause a false increase in 
mean corpuscular volume (MCV). Prewarming of the EDTA-an-
ticoagulated blood specimen at 37°C for 10-15 min is required 
to obtain reliable CBC results, the red cell parameters of the CBC 
in particular. 
 Cryoproteinemia has been associated with falsely increased 
WBC counts, falsely increased platelet counts, or both. Pre-in-
cubation of cryoproteinemic blood specimen at 37°C for 10-15 
min often yields reliable CBC results, the WBC count in particu-
lar. Red cell rouleaux, if seen in the thin readable area of the 
smear, is indicative of elevated levels of fibrinogen and/or globu-
lins. It is often associated with inflammatory or infectious condi-
tions and/or malignant disorders, such as multiple myeloma 
and macroglobulinemia. It usually does not adversely affect the 
CBC and DIFF results. The presence of fibrin strands reflects 
questionable specimen integrity and is therefore a justification 
for withholding or cancelling the reported CBC results, the plate-
let count in particular. Damaged leukocytes, primarily granulo-
cytes, denuded of their cell wall, with somewhat fuzzy-appearing 
red cells on the smear, are suggestive of hyperlipidemia. Severe 
hyperlipidemia causes a false increase in hemoglobin, MCH 
and MCHC. Reliable CBC results, the Hb, MCH and MCHC in 
particular, can be obtained from hyperlipidemic specimens by 
centrifuging the EDTA-anticoagulated blood specimen, replac-
ing the plasma with an equal amount of isotonic diluent, and re-
running through the analyzer.
 After verifying the flagged automated CBC results and deter-
mining if the manual DIFF needs to be performed based upon 
the initial smear scan findings, typically a 100-cell DIFF is per-
formed. Each white cell type is identified and classified into indi-
vidual cell category until 100 white cells are counted. Total num-
ber of white cells counted may vary from the traditional 100-cell 
count if and when the WBC count is either lower than normal or 
greater than normal. One may count as low as 25 white cells or 
as high as 200 or 300 white cells depending upon the WBC 
count. Manual counters, laboratory information system (LIS)-
based DIFF keyboards, and/or automated neural-network-based 
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systems (such as Cellavision) may be used to perform the DIFF. 
The results have traditionally been reported as a percentage of 
each cell-type but many, if not all, LIS-based DIFF keyboards 
can be set-up to also automatically calculate and report the ab-
solute number of each cell-type, in addition to the results in 
percentage. The absolute numbers are generally considered 
more valuable because they reflect absolute and thereby the 
true increase or decrease in the number of each cell type. How-
ever, in the clinical arena, even a relative increase in percentage 
of bands in leukopenic patients has arguably received some 
credence towards sepsis work-up. 
 Completion of DIFF count is generally followed by evaluation 
of morphology of red cells, white cells, and platelets. Over the 
years, the lack of availability of a standardized approach to re-
porting the results of morphologic evaluation of blood cells have 
led laboratories to report the findings in a variety of ways with lit-
tle, if any, attention being paid to maintaining consistency. Some 
laboratories choose to report individual specific abnormalities 
simply as present when seen in the smear, whereas others opt 
to grade individual abnormalities either as mild, moderate or 
marked or as 1+ through 4+. A grading system, whether in 
terms of mild, moderate and marked or 1+ to 4+, for reporting 
of morphologic findings is clinically useful at least in some 
cases. For example, a finding reported as 3+, 4+ or marked el-
liptocytes is essentially diagnostic of hereditary elliptocytosis. 
Similarly, a finding reported as 3+, 4+, or marked tear drop cells 
is highly suggestive of bone marrow fibrosis. In contrast, a find-
ing reported as elliptocytes present or tear drop cells present is 
considered non-specific because a small number of elliptocytes 
may be seen in the blood smears of patients with anemia of var-
ious etiologies and an occasional tear drop cell is not an uncom-
mon finding in patients with iron deficiency anemia or renal dis-
ease. Blood Cell Morphology Grading Guide, a recent publica-
tion from the American Society for Clinical Pathology Press 
(ASCP Press), provides a systematic approach and thereby 
some level of standardization to grading and reporting morpho-
logic abnormalities of red cells, white cells and platelets [18]. 
Upon completion of the evaluation of blood cells morphology, 
the next step is to record other clinically significant findings, if 
any present, such as the presence of intracellular and/or extra-
cellular organisms, non-heme malignant cells, etc. The blood 
smear examination is often completed with (i) qualitative platelet 
estimate reported as normal, increased or decreased and (ii) a 
determination by the blood smear examiner as to whether the 
smear needs a review and/or interpretation of findings by a he-
matomorphologist and/or a pathologist.
3. Blood Smear Review (BSR)
Synonyms: blood smear interpretation, physician review 
of blood smear.
A BSR may be requested by the clinician or initiated by the lab-
oratory staff. It may be performed with or without interpretation 
of findings. Clinical indications for a blood smear review request 
by a physician include (a) unexplained anemia, thrombocytope-
nia and/or leukopenia, (b) suspicion of microangiopathic hemo-
lytic anemia (e.g., thrombotic thrombocytopenic purpura, dis-
seminated intravascular coagulation, etc), hemoglobinopathy 
(e.g., SS, SC, CC, etc.), thalassemia, red cell membranopathy 
(e.g., hereditary elliptocytosis, hereditary spherocytosis, etc.), 
lymphoproliferative disorder, plasma cell dyscrasia, myeloprolif-
erative disorder, myelodysplastic syndrome, parasitic infection, 
infectious mononucleosis, inherited leukocyte disorder (e.g., 
Pelger huet, May-Hegglin, etc.), or inherited platelet disorder 
(e.g., gray platelet syndrome). The laboratory staff usually initi-
ates a blood smear review either as good laboratory practice 
and/or as required by regulatory or professional accreditation 
agencies in many countries around the globe. In many laborato-
ries, at least the initial blood smears with potentially significant 
finding(s), as determined by the pre-set criteria, are subjected 
to a review by a qualified hematomorphologist. Any person with 
expertise in blood cell morphology may serve as a qualified re-
viewer for confirmation of previously identified abnormal find-
ings and for identifying those either unfamiliar to or missed by 
the initial blood smear examiner. However, a physician, that may 
be a hematopathologist, hematologist, or pathologist with train-
ing and experience in hematology, is most suitable for interpre-
tation of blood smear findings in the light of other relevant clini-
cal and laboratory information. 
 The list of criteria for smear review is usually developed by in-
dividual laboratories with input from pathologist(s), clinicians, 
and the hematology supervisory staff, and may be updated peri-
odically as deemed appropriate. Although, clinical significance 
of the abnormal CBC and DIFF findings is the major determin-
ing factor in deciding which blood smears need review, several 
other factors may also influence such a decision. These factors 
may include patient population served, clinicians’ concerns 
pertaining to specific patient populations, training and experi-
ence of blood smear examiners(s) and reviewer(s), workload of 
the laboratory and the reviewer(s), initial vs. follow-up smears, 
QC/quality assurance (QA) consideration, and teaching/educa-
tional considerations. Published criteria [19-22] may be used by 
individual laboratories as a starting point in the process of devel-
oping their own set of criteria. The set of criteria utilized by the 
Gulati G, et al.
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Clinical Hematology Laboratory at Thomas Jefferson University 
Hospital for review of blood smears by a Hematopathologist is 
provided here as an example (Tables 2 and 3) .
 Blood smear review by a qualified hematomorphologist can 
serve several functions that are considered essential to good pa-
tient care. It can serve as a quality assurance tool for the CBC, 
DIFF (automated and/or manual), and reticulocyte count re-
sults, manual DIFF in particular, because there is no other com-
mercially available QC material for daily use for this test. Inter-
pretation of blood smear findings along with CBC and other 
available laboratory data in the clinical context may provide a 
definite diagnosis or suggest a strategy for additional work-up of 
the case in an efficient and cost-effective manner. Furthermore, 
blood smear review can serve as an excellent teaching resource 
for training of students, residents, fellows and newly hired staff, 
and for continuing education of the technical staff.
 Blood smear review process encompasses every aspect of 
the blood smear scan and the blood smear examination de-
scribed above, with one exception. The exception is that the re-
Table 2. Criteria for blood smear review at Thomas Jefferson University Hospital  
Adults Infants
A. Based on CBC  
WBC (×109/L) Initial* >30
RBC (×1012/L) Initial >6.0 (Female) or >6.5 (Male)
Hb (g/dL) Initial ≤6 or >18 <14 ( newborn)
  (mmol/L) ≤3.7 or >11.2
PLT (×109/L) Initial <50 or >999
MCV (fL) Initial <60 or >110 <  85 (newborn)
B. Based on automated DIFF (×109/L)
Lymphocytes Initial >7 (>14 yr old) >10 (1-14 yr old) >14 (<1 yr old)
Monocytes Initial >3 (>7 days old)
Eosinophils Initial >2
Basophils Initial >0.5
C. Based on manual Diff
Blasts or other abnormal/unclassifiable cells Any
Promyelocytes Initial ≥3%
Myelocytes Initial ≥5%
Metamyelocytes Initial ≥10%
Reactive Lymphocytes Initial ≥10%
NRBC (per 100 WBC) Initial over 2 (>7 days old) over 50 (<7 days old)
Significant morphologic abnormalities (Initial) of: RBC, WBC, and PLT (see Table 3)
Organisms Any
D. Request from a Clinician
*Initial: first smear on a new patient per admission or an infrequent outpatient visit.
Abbreviations: CBC, complete blood count; WBC, white blood cell; RBC, red blood cell; PLT, platelet; MCV, mean corpuscular volume; DIFF, differential leu-
kocyte count; NRBC, nucleated red blood cell.
Table 3. Significant morphologic abnormalities
Red Blood Cells
A nisocytosis, poikilocytosis, elliptocytes, hypochromia, polychromasia, 
basophilic stippling, stomatocytes
(≥3+)
Target cells, rouleaux (≥2+)
Schistocytes, spherocytes, acanthocytes, tear drop cells (≥1+)
Sickle cells, Howell Jolly bodies, Pappenheimer bodies, agglutination (Any)
White Blood Cells
Döhle bodies (≥3+)
Hyposegmented neutrophils (≥2+)
Hypersegmented neutrophils (≥1+)
Hypogranular neutrophils (≥1+)
Auer rods (Any)
Platelets
Giant/large platelets (≥2+)
Agranular platelets (≥2+)
Bizarre platelets (≥1+)
Platelet satellitosis (≥1+)
Gulati G, et al.
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viewer may or may not choose to perform the actual 100-cell 
DIFF. The circumstances, which will necessitate a 100-cell DIFF 
by the reviewer include (a) if the review is being performed also 
for the purpose of QC for the DIFF or for assessing competency 
of the staff in performing manual DIFF and (b) if, in the judge-
ment of the reviewer, the DIFF results reported by the blood 
smear examiner are either incomplete, inaccurate, or contain 
some unidentifiable cells reported as other cells with or without 
any comments. A blood smear review by a physician often gen-
erates a written report with interpretation of the findings in the 
clinical context. Blood smear reviewers often serve as consul-
tants to clinicians and other laboratory professionals in explain-
ing the abnormal findings and their clinical relevance, besides 
providing either a diagnosis whenever feasible or suggesting an 
appropriate strategy for an efficient and cost-effective additional 
work-up necessary for arriving at a diagnosis. At our institution, 
all initial blood smears meeting the pre-set criteria (Tables 2 and 
3) are reviewed by a Hematopathologist and all follow-up smears 
meeting pre-set criteria (presence of any blast and/or organisms) 
are reviewed by an experienced technologist with good morpho-
logical skills.
SUMMARY
A blood smear scan serves to at least (a) verify the flagged auto-
mated hematology results and (b) determine if a manual DIFF 
needs to be performed. Blood smear examination/Manual DIFF 
with CBC provides the complete hematologic picture of the case, 
at least from the morphologic standpoint. Blood smear review 
with or without interpretation serves to ensure that no clinically 
significant finding is missed, besides providing diagnosis or diag-
nostic clue(s), particularly if and when interpreted by a physician.
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